ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,537.02
      0.51%
      US Tech 100
      19,641.60
      0.83%
      Dow Jones
      39,308.00
      -0.06%
      Brent Oil
      87.03
      0.14%
      Bitcoin
      57,289.36
      -4.78%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Axovant Gene Therapies Ltd (AXGT)

      7. Axovant Gene Therapies Ltd (AXGT) News

      AXGT

      Axovant Gene Therapies (AXGT)

      Axovant Gene Therapies Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AXGT
      DateTimeSourceHeadlineSymbolCompany
      09/25/20194:05PMGlobeNewswire Inc.Axovant Gene Therapies to Present at 2019 Cell & Gene Meeting on the MesaNASDAQ:AXGTAxovant Gene Therapies Ltd
      09/24/20195:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AXGTAxovant Gene Therapies Ltd
      09/24/20195:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AXGTAxovant Gene Therapies Ltd
      09/24/20195:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AXGTAxovant Gene Therapies Ltd
      09/24/20195:13PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AXGTAxovant Gene Therapies Ltd
      09/06/20195:07PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AXGTAxovant Gene Therapies Ltd
      09/06/20197:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AXGTAxovant Gene Therapies Ltd
      08/16/20194:04PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AXGTAxovant Gene Therapies Ltd
      08/09/20197:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AXGTAxovant Gene Therapies Ltd
      08/09/20197:00AMGlobeNewswire Inc.Axovant Announces Corporate Updates and Financial Results for First Fiscal Quarter Ended June 30, 2019NASDAQ:AXGTAxovant Gene Therapies Ltd
      08/09/20196:57AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AXGTAxovant Gene Therapies Ltd
      07/29/20194:28PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AXGTAxovant Gene Therapies Ltd
      07/17/20196:01AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AXGTAxovant Gene Therapies Ltd
      07/16/20195:31PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AXGTAxovant Gene Therapies Ltd
      07/16/20195:31PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AXGTAxovant Gene Therapies Ltd
      07/16/20195:01PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AXGTAxovant Gene Therapies Ltd
      07/15/20199:23AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AXGTAxovant Gene Therapies Ltd
      07/12/20197:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AXGTAxovant Gene Therapies Ltd
      07/12/20195:06PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AXGTAxovant Gene Therapies Ltd
      07/12/20194:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AXGTAxovant Gene Therapies Ltd
      07/12/20194:47PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AXGTAxovant Gene Therapies Ltd
      07/12/20194:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AXGTAxovant Gene Therapies Ltd
      07/12/20194:30PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AXGTAxovant Gene Therapies Ltd
      07/02/20196:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AXGTAxovant Gene Therapies Ltd
      07/02/20195:31PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AXGTAxovant Gene Therapies Ltd
      07/01/20196:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AXGTAxovant Gene Therapies Ltd
      07/01/20196:04PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AXGTAxovant Gene Therapies Ltd
      07/01/20195:04PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AXGTAxovant Gene Therapies Ltd
      07/01/20197:00AMGlobeNewswire Inc.Axovant Appoints David Nassif as Chief Financial Officer and Expands Board of DirectorsNASDAQ:AXGTAxovant Gene Therapies Ltd
      06/24/20197:01AMGlobeNewswire Inc.Axovant Announces Poster Presentations at the 5th Congress of the European Academy of NeurologyNASDAQ:AXGTAxovant Gene Therapies Ltd
       Showing the most relevant articles for your search:NASDAQ:AXGT